Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00333697 · ClinicalTrials.gov registry record · NA
Single Comprehensive Ultrasound to Rule Out DVT in High-risk Patients
A NA study, sponsored by Intermountain Health Care.
- Completed
- Registry status
- NA
- Development phase
- 199
- Enrollment target
NCT00333697 is a NA study that has completed, run by Intermountain Health Care. The registered enrollment target is 199 participants.
The verdict
NCT00333697, a NA study, has completed, sponsored by Intermountain Health Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 199 participants
- Enrollment target
Study Summary
To determine the rate of thromboembolic complications (including death attributed to thromboembolic disease) in patients with a score rated as "DVT likely" on a formalized scoring system, when anticoagulation therapy is withheld on the basis of a negative comprehensive duplex ultrasound examination. Participants are followed for three months after a normal ultrasound to determine if any symptoms attributable to deep vein thrombosis develop. Any such symptoms are verified by objective tests.
Interventions
- OTHER Comprehensive Duplex Ultrasound (diagnostic study)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 199 participants |
| Start Date | 2005-11 |
| Est. Completion | 2011-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00333697
The ClinicalTrials.gov registry entry for NCT00333697 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 199 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Intermountain Health Care, which has 85 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Comprehensive Duplex Ultrasound (diagnostic study) is the first listed.
NCT00333697 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00333697 about?
NCT00333697 is a clinical study titled "Single Comprehensive Ultrasound to Rule Out DVT in High-risk Patients". To determine the rate of thromboembolic complications (including death attributed to thromboembolic disease) in patients with a score rated as "DVT likely" on a formalized scoring system, when anticoagulation therapy is withheld on the basis of a negative comprehensive duplex ultrasound examination....
What is the current status of trial NCT00333697?
This trial is currently completed. It is a NA study. The enrollment target is 199 participants. The study started on 2005-11. Estimated completion is 2011-01.
What interventions are being tested in trial NCT00333697?
The interventions under investigation include: Comprehensive Duplex Ultrasound (diagnostic study) (OTHER).
Who is sponsoring clinical trial NCT00333697?
This trial is sponsored by Intermountain Health Care, which has 85 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.